SOPHARMA AD: Current report 10 23012013 ENG

opublikowano: 2013-01-23 14:47

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_10_23012013_ENG.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 10 / 2013
Date of issue: 2013-01-23
Short name of the issuer
SOPHARMA AD
Subject
Current report 10 23012013 ENG
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of Sopharma AD (the “Company") hereby notifies that on 23 January 2013 Sopharma AD received a notification of disclosure of shareholdings from Financial Consulting Company regarding the selling of 4 053 002 shares. After this transaction the share of Financial Consulting Company in the capital of Sopharma AD decreased below 10% to 9.62 %.
The date of registration of the transaction with the Central Depository AD is 23 January 2013.
Annexes
File Description
Current report 10 23012013 ENG.docCurrent report 10 23012013 ENG.doc Current report 10 23012013 ENG

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-01-23 Ognian Donev Executive Director